On 24 November 2025, Novo Nordisk reported that oral semaglutide had failed to slow Alzheimers disease in the EVOKE and EVOKE+ trials, which together enrolled 3,808 participants and stand as the largest evaluation of this drug class in any neurodegenerative condition [1]
TikTok shop already banned all GLP-1 supplements
Ipamorelin vs Sermorelin Ipamorelin and Sermorelin represent two distinct mechanistic approaches to growth hormone stimulation
Reporting of side effects: If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet
It has already moved into larger, late-stage trials
Mostly importantly, administration of TAK-475 largely reversed all phenotypes caused by cholesterol feeding (Fig